Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Novelix Pharmaceuticals has closed its trading window for insiders and their relatives from June 1, 2026, ahead of a Board meeting scheduled for June 4, 2026. The Board will consider a proposal to raise funds through a preferential issue or any other permissible mode, or a combination of these. The trading window will reopen 48 hours after the Board meeting outcome is shared with the stock exchanges. The intimation has been signed by Whole-time Director Venkateshwarlu Pulluru.
For shareholders, this signals that the company is likely preparing to announce a fund-raising move soon, which could lead to dilution depending on the mode and size of the issue. Short-term price action may be muted until the Board decision is disclosed.